Compare Amphastar Pharmaceuticals Inc (AMPH) vs D Wave Quantum Inc (QBTS) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

D-Wave Quantum (QBTS) trades at $20.74, up 6.85% today, with strong bullish technical signals from moving averages. The stock shows extreme valuation metrics with P/S of 582.68 and negative profitability, though 100% of analysts maintain buy ratings with a $38.78 consensus target. Recent Q2 2026 results missed revenue expectations but showed a 1,120% surge in bookings, highlighting the speculative growth nature of this quantum computing play.

The outlook remains speculative with significant execution risk given negative cash flows and mounting losses, but potential exists if quantum computing adoption accelerates. Investors face high volatility amid ongoing operational losses despite strong analyst conviction and institutional interest in this emerging technology sector.